251 related articles for article (PubMed ID: 26582922)
1. SureChEMBL: a large-scale, chemically annotated patent document database.
Papadatos G; Davies M; Dedman N; Chambers J; Gaulton A; Siddle J; Koks R; Irvine SA; Pettersson J; Goncharoff N; Hersey A; Overington JP
Nucleic Acids Res; 2016 Jan; 44(D1):D1220-8. PubMed ID: 26582922
[TBL] [Abstract][Full Text] [Related]
2. Exploring SureChEMBL from a drug discovery perspective.
Gadiya Y; Shetty S; Hofmann-Apitius M; Gribbon P; Zaliani A
Sci Data; 2024 May; 11(1):507. PubMed ID: 38755219
[TBL] [Abstract][Full Text] [Related]
3. Managing expectations: assessment of chemistry databases generated by automated extraction of chemical structures from patents.
Senger S; Bartek L; Papadatos G; Gaulton A
J Cheminform; 2015 Dec; 7(1):49. PubMed ID: 26457120
[TBL] [Abstract][Full Text] [Related]
4. Chemical named entity recognition in patents by domain knowledge and unsupervised feature learning.
Zhang Y; Xu J; Chen H; Wang J; Wu Y; Prakasam M; Xu H
Database (Oxford); 2016; 2016():. PubMed ID: 27087307
[TBL] [Abstract][Full Text] [Related]
5. Annotated chemical patent corpus: a gold standard for text mining.
Akhondi SA; Klenner AG; Tyrchan C; Manchala AK; Boppana K; Lowe D; Zimmermann M; Jagarlapudi SA; Sayle R; Kors JA; Muresan S
PLoS One; 2014; 9(9):e107477. PubMed ID: 25268232
[TBL] [Abstract][Full Text] [Related]
6. Identification of the Core Chemical Structure in SureChEMBL Patents.
Falaguera MJ; Mestres J
J Chem Inf Model; 2021 May; 61(5):2241-2247. PubMed ID: 33929850
[TBL] [Abstract][Full Text] [Related]
7. Exploring sets of molecules from patents and relationships to other active compounds in chemical space networks.
Kunimoto R; Bajorath J
J Comput Aided Mol Des; 2017 Sep; 31(9):779-788. PubMed ID: 28871390
[TBL] [Abstract][Full Text] [Related]
8. Automatic identification of relevant chemical compounds from patents.
Akhondi SA; Rey H; Schwörer M; Maier M; Toomey J; Nau H; Ilchmann G; Sheehan M; Irmer M; Bobach C; Doornenbal M; Gregory M; Kors JA
Database (Oxford); 2019 Jan; 2019():. PubMed ID: 30698776
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the significance of patent-derived information for the early identification of compound-target interaction hypotheses.
Senger S
J Cheminform; 2017 Apr; 9(1):26. PubMed ID: 29086108
[TBL] [Abstract][Full Text] [Related]
10. Illuminating the druggable genome through patent bioactivity data.
Magariños MP; Gaulton A; Félix E; Kiziloren T; Arcila R; Oprea TI; Leach AR
PeerJ; 2023; 11():e15153. PubMed ID: 37151295
[TBL] [Abstract][Full Text] [Related]
11. Building structure-activity insights through patent mining.
Tu M; Pfefferkorn JA; Guzman-Perez A; Filipski KJ
Pharm Pat Anal; 2012 Nov; 1(5):545-54. PubMed ID: 24236924
[TBL] [Abstract][Full Text] [Related]
12. CIPSI: An open chemical intellectual property service for medicinal chemists.
Martinez-Sevillano M; Falaguera MJ; Mestres J
Mol Inform; 2024 Jan; 43(1):e202300221. PubMed ID: 38010631
[TBL] [Abstract][Full Text] [Related]
13. An advanced search engine for patent analytics in medicinal chemistry.
Pasche E; Gobeill J; Teodoro D; Gaudinat A; Vishnykova D; Lovis C; Ruch P
Stud Health Technol Inform; 2012; 180():204-9. PubMed ID: 22874181
[TBL] [Abstract][Full Text] [Related]
14. Ontology-based content analysis of US patent applications from 2001-2010.
Weber L; Böhme T; Irmer M
Pharm Pat Anal; 2013 Jan; 2(1):39-54. PubMed ID: 24236969
[TBL] [Abstract][Full Text] [Related]
15. The Natural Products Atlas: An Open Access Knowledge Base for Microbial Natural Products Discovery.
van Santen JA; Jacob G; Singh AL; Aniebok V; Balunas MJ; Bunsko D; Neto FC; Castaño-Espriu L; Chang C; Clark TN; Cleary Little JL; Delgadillo DA; Dorrestein PC; Duncan KR; Egan JM; Galey MM; Haeckl FPJ; Hua A; Hughes AH; Iskakova D; Khadilkar A; Lee JH; Lee S; LeGrow N; Liu DY; Macho JM; McCaughey CS; Medema MH; Neupane RP; O'Donnell TJ; Paula JS; Sanchez LM; Shaikh AF; Soldatou S; Terlouw BR; Tran TA; Valentine M; van der Hooft JJJ; Vo DA; Wang M; Wilson D; Zink KE; Linington RG
ACS Cent Sci; 2019 Nov; 5(11):1824-1833. PubMed ID: 31807684
[TBL] [Abstract][Full Text] [Related]
16. Opening up connectivity between documents, structures and bioactivity.
Southan C
Beilstein J Org Chem; 2020; 16():596-606. PubMed ID: 32280387
[TBL] [Abstract][Full Text] [Related]
17. Expanding opportunities for mining bioactive chemistry from patents.
Southan C
Drug Discov Today Technol; 2015 Jul; 14():3-9. PubMed ID: 26194581
[TBL] [Abstract][Full Text] [Related]
18. Extracting and connecting chemical structures from text sources using chemicalize.org.
Southan C; Stracz A
J Cheminform; 2013 Apr; 5(1):20. PubMed ID: 23618056
[TBL] [Abstract][Full Text] [Related]
19. ChEMBL: a large-scale bioactivity database for drug discovery.
Gaulton A; Bellis LJ; Bento AP; Chambers J; Davies M; Hersey A; Light Y; McGlinchey S; Michalovich D; Al-Lazikani B; Overington JP
Nucleic Acids Res; 2012 Jan; 40(Database issue):D1100-7. PubMed ID: 21948594
[TBL] [Abstract][Full Text] [Related]
20. AI-driven molecular generation of not-patented pharmaceutical compounds using world open patent data.
Shimizu Y; Ohta M; Ishida S; Terayama K; Osawa M; Honma T; Ikeda K
J Cheminform; 2023 Dec; 15(1):120. PubMed ID: 38093324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
